Hepatitis B and end-stage liver disease. Review uri icon

Overview

abstract

  • Hepatitis B virus (HBV) is the most common cause of chronic hepatitis and end-stage liver disease worldwide. Untreated, chronic hepatitis B acquired early in life results in cirrhosis, liver failure, or hepatocellular carcinoma in up to 40% of individuals. Until recently, the options for a patient who had end-stage hepatitis B cirrhosis were severely limited, but during the past 15 years great strides have been made in prevention and treatment of hepatitis B cirrhosis. This article reviews recent advances in the understanding of the natural history, prevention, and medical management of HBV-related end-stage liver disease.

publication date

  • November 1, 2007

Research

keywords

  • Hepatitis B virus
  • Hepatitis B, Chronic
  • Liver Cirrhosis
  • Liver Failure

Identity

Scopus Document Identifier

  • 35548946090

Digital Object Identifier (DOI)

  • 10.1016/j.cld.2007.08.009

PubMed ID

  • 17981234

Additional Document Info

volume

  • 11

issue

  • 4